How is St. Jude moving into the area of drug development?
In 2005 we started a new department called chemical biology and therapeutics and it’s an enterprise within St. Jude that’s not that much different than what you’d find at Merck or Glaxo or Pfizer that’s using modern technology, robotics, high put-through screen systems that find a drug that hit a target that causes the disease. Scientists at St. Jude discovered these hits that caused childhood cancers were different than the hits that cause adult cancers.
